Zobrazeno 1 - 9
of 9
pro vyhledávání: '"N. C. Karyotakis"'
Autor:
Elias Anaissie, N. C. Karyotakis
Publikováno v:
Current Opinion in Infectious Diseases. 7:658-666
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9659c3a6cc7833902357fce7d4e7d45
https://doi.org/10.1097/00001432-199412000-00005
https://doi.org/10.1097/00001432-199412000-00005
Autor:
M. C. Dignani, C. K. Tin-U, Elias Anaissie, Ayse Gokaslan, L. C. Stephens, Ray Y Hachem, N. C. Karyotakis
Publikováno v:
Antimicrobial Agents and Chemotherapy. 38:2541-2544
We assessed the activities of amphotericin B deoxycholate, liposomal amphotericin B, fluconazole, and SCH 39304 against 10 strains of Trichosporon beigelii in mice with hematogenous infections. Cyclophosphamide-immunosuppressed CF1 male mice were cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::675d86dff56b4b1fbd5f25f4c4fe48e8
https://doi.org/10.1128/aac.38.11.2541
https://doi.org/10.1128/aac.38.11.2541
Autor:
Ray Y Hachem, N. C. Karyotakis, John H. Rex, Victor L. Paetznick, Elias Anaissie, M. C. Dignani
Publikováno v:
Journal of Infectious Diseases. 170:384-389
The correlation between antifungal susceptibility testing and in vivo response to antifungal therapy was examined in experimental murine candidiasis. In vitro susceptibility testing was done using a microbroth dilution method. Twenty-two Candida albi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c827da15c6bbf9c9736e50b6d3f0ab
https://doi.org/10.1093/infdis/170.2.384
https://doi.org/10.1093/infdis/170.2.384
Autor:
E. Barbounakis, E J Anaissie, George Samonis, G P Bodey, Sofia Maraki, Yiannis Tselentis, N C Karyotakis
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:2221-2223
Adult male Crl:CD1 (ICR) mice were fed chow containing Candida albicans to induce sustained gastrointestinal colonization by the yeast. Groups of mice were rendered neutropenic with cyclophosphamide and subsequently received ceftriaxone, while other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d518ca77fa99605e47759352a06fc214
https://doi.org/10.1128/aac.40.9.2221
https://doi.org/10.1128/aac.40.9.2221
Publikováno v:
Antimicrobial Agents and Chemotherapy. 39:775-777
Candida krusei is increasingly recognized as an opportunistic pathogen in immunocompromised patients and is inherently resistant to fluconazole. We tested the in vivo efficacy of SCH 51048, an investigational antifungal triazole, in experimental hema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4c8e4d41bf370d7c994c361c503bd75
https://doi.org/10.1128/aac.39.3.775
https://doi.org/10.1128/aac.39.3.775
Publikováno v:
Journal of Infectious Diseases. 168:1311-1313
Candida krusei is reported to cause serious infections in immunocompromised patients, particularly those receiving prophylaxis with antifungal azoles. Treatment of this infection can be very challenging. The efficacy of amphotericin B, liposomal amph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc5f5d7d3f722d99f2fe6b1a17acce9
https://doi.org/10.1093/infdis/168.5.1311
https://doi.org/10.1093/infdis/168.5.1311
Publikováno v:
Antimicrobial agents and chemotherapy. 39(2)
Candida lusitaniae and Trichosporon beigelii may cause life-threatening infections in the immunocompromisedhostandmayberesistanttoamphotericinB.Weassessedtheactivitiesofanewtriazole,D0870,against one T. beigelii and four C. lusitaniae strains, in com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ff9edeb7990898eeb9b4d3f16254419
https://pubmed.ncbi.nlm.nih.gov/7726538
https://pubmed.ncbi.nlm.nih.gov/7726538
Autor:
N. C. Karyotakis, Elias Anaissie
Publikováno v:
Antimicrobial agents and chemotherapy. 38(11)
Immunosuppressed CF1 mice were infected intravenously with two strains of Candida krusei and four strains of Candida lusitaniae (two of which were resistant to amphotericin B). Mice were treated with 1 or 2 mg of amphotericin B desoxycholate per kg o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db162cb59de00d453d1eca764d83f118
https://pubmed.ncbi.nlm.nih.gov/7872764
https://pubmed.ncbi.nlm.nih.gov/7872764
Autor:
N. C. Karyotakis, Elias Anaissie
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:2907-2908
Candida lusitaniae may cause life-threatening infections in the immunocompromised host and may be resistant to amphotericin B. Flucytosine (5-FC) is very active against C. lusitaniae isolates in vitro, while the in vivo response of murine infection t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a418a82444574d7d73719145d3d75146
https://doi.org/10.1128/aac.40.12.2907
https://doi.org/10.1128/aac.40.12.2907